CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cepsilon transcription in a human B cell line

Arch Biochem Biophys. 2002 Sep 15;405(2):199-204. doi: 10.1016/s0003-9861(02)00369-7.

Abstract

Induction of germline C epsilon transcription in B cells by IL-4, which is a critical initiating step for IgE class switching, is enhanced by CD40 engagement. Although signaling by CD40 is initiated by the binding of tumor necrosis factor receptor-associated factor (TRAF) family members to its cytoplasmic domain, whether those TRAF family proteins mediate enhancement of germline Cepsilon transcription is not evident. We report here that CD40-induced TRAF3-dependent activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase 1 (MEK1) is involved in the upregulation of IL-4-driven germline C epsilon transcription in a human Burkitt's lymphoma B cell line, DG75. Among the six known TRAF proteins, TRAF2, 3, 5, and 6 associated with CD40 in an unstimulated state, and the levels of these four proteins were unaffected by anti-CD40 stimulation. Antisense oligodeoxynucleotide (ODN) for TRAF3 inhibited CD40-induced activation of MEK1-ERK pathway by decreasing expression of TRAF3 protein, but antisense ODNs for TRAF2, 5, and 6 were ineffective. Furthermore, CD40-mediated enhancement of IL-4-driven germline C epsilon transcription was inhibited by antisense ODN for TRAF3 and by a MEK1 inhibitor, PD98059. These results suggest that in DG75 cells, TRAF3-induced MEK1 activation may be involved in CD40-mediated upregulation of IL-4-driven germline C epsilon transcription.

MeSH terms

  • Burkitt Lymphoma / physiopathology*
  • CD40 Antigens / drug effects
  • CD40 Antigens / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Germ Cells
  • Humans
  • Immunoglobulin epsilon-Chains / drug effects
  • Immunoglobulin epsilon-Chains / genetics*
  • Immunoglobulin epsilon-Chains / metabolism
  • Interleukin-4 / metabolism*
  • Interleukin-4 / pharmacology
  • MAP Kinase Kinase 1
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Oligonucleotides, Antisense / pharmacology
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism
  • Proteins / drug effects
  • Proteins / genetics
  • Proteins / metabolism*
  • TNF Receptor-Associated Factor 2
  • TNF Receptor-Associated Factor 3
  • TNF Receptor-Associated Factor 5
  • TNF Receptor-Associated Factor 6
  • Transcription, Genetic*
  • Tumor Cells, Cultured
  • Up-Regulation

Substances

  • CD40 Antigens
  • Enzyme Inhibitors
  • Flavonoids
  • Immunoglobulin epsilon-Chains
  • Oligonucleotides, Antisense
  • Proteins
  • TNF Receptor-Associated Factor 2
  • TNF Receptor-Associated Factor 3
  • TNF Receptor-Associated Factor 5
  • TNF Receptor-Associated Factor 6
  • Interleukin-4
  • Protein Serine-Threonine Kinases
  • MAP Kinase Kinase 1
  • MAP2K1 protein, human
  • Mitogen-Activated Protein Kinase Kinases
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one